Novo Nordisk (NVO) stock is dipping after the company's outlook disappointed investors. Yahoo Finance Executive Editor Brian Sozzi shares his thoughts on the stock, the company's trajectory, and where Eli Lilly (LLY) fits into the equation. Video Transcript 00:00 Speaker A Now, another one I'm watching too and this comes top of mind because a couple weeks ago I had Michael Dutar uh on speaking of new CEOs on my on my podcast, Power players. and you should go check it out. It was a really good chat. I think Mike just he flung it. he flung it. He just let it fly. He just said about, you know, where we have lost market share, we need to do marketing a lot better. We need to do a better job.
Wir zeigen den wichtigsten Punkt oeffentlich. Erstellen Sie ein kostenloses Konto, um den vollstaendigen Artikel zu lesen, ihn zu speichern, zu diskutieren und mit Markt- und OSINT-Kontext zu verbinden.